Sign In
Buy ZYME
$22.86
-0.260 (-1.12%)
At Close: Jul 24, 2026
Levi & Korsinsky Announces an Investigation on Behalf of Zymeworks Inc. (ZYME) Shareholders Who May Have Been Affected by Fraud
07:30am, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. ("Zymeworks") (NASDAQ:ZYME) concerning possible violations of fe
Investors who lost money on Zymeworks Inc. should contact Levi & Korsinsky about an ongoing investigation - ZYME
07:30am, Monday, 13'th May 2024
NEW YORK, NY / ACCESSWIRE / May 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. ("Zymeworks") (NASDAQ:ZYME) concerning possible violations of fe
NEW YORK, NY / ACCESSWIRE / May 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. ("Zymeworks") (NASDAQ:ZYME) concerning possible violations of fe
Shareholders that lost money on Zymeworks Inc.(ZYME) should contact Levi & Korsinsky about Securities Fraud Investigation - ZYME
10:30pm, Wednesday, 08'th May 2024
NEW YORK, NY / ACCESSWIRE / May 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. ("Zymeworks") (NASDAQ:ZYME) concerning possible violations of fed
Shareholder Rights Advocates at Levi & Korsinsky Investigate Zymeworks Inc. (ZYME) Regarding Possible Securities Fraud Violations
07:22am, Wednesday, 08'th May 2024
NEW YORK, NY / ACCESSWIRE / May 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. ("Zymeworks") (NASDAQ:ZYME) concerning possible violations of fed
ATTENTION Zymeworks Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
08:30pm, Monday, 06'th May 2024
NEW YORK, NY / ACCESSWIRE / May 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. ("Zymeworks") (NASDAQ:ZYME) concerning possible violations of fed
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
07:38pm, Monday, 06'th May 2024
NEW YORK , May 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. ("Zymeworks" or the "Company") (NASDAQ: ZYME). Such investors are advised to conta
Zymeworks Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - ZYME
07:40am, Monday, 06'th May 2024
NEW YORK, NY / ACCESSWIRE / May 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. ("Zymeworks") (NASDAQ:ZYME) concerning possible violations of fed
Lost Money on Zymeworks Inc.(ZYME)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
09:15pm, Thursday, 02'nd May 2024
NEW YORK, NY / ACCESSWIRE / May 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. ("Zymeworks") (NASDAQ:ZYME) concerning possible violations of fed
Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript
08:04pm, Thursday, 02'nd May 2024
Zymeworks Inc. (NASDAQ:ZYME ) Q1 2024 Earnings Call Transcript May 2, 2024 4:30 PM ET Company Participants Shrinal Inamdar - Director, Investor Relations Ken Galbraith - Chair and CEO Paul Moore - Chi
Zymeworks Inc. (ZYME) Reports Q1 Loss, Misses Revenue Estimates
07:41pm, Thursday, 02'nd May 2024
Zymeworks Inc. (ZYME) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.37 per share a year ago.
ATTENTION Zymeworks Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
11:00am, Thursday, 02'nd May 2024
NEW YORK, NY / ACCESSWIRE / May 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Zymeworks Inc. ("Zymeworks") (NASDAQ:ZYME) concerning possible violations of fed
Zymeworks Announces Participation in Upcoming Investor Conferences
06:00am, Tuesday, 30'th Apr 2024
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherape
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
09:45am, Sunday, 28'th Apr 2024
NEW YORK , April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. ("Zymeworks" or the "Company") (NASDAQ: ZYME). Such investors are advised to c
3 Top Stocks to Invest in for Amazing Earnings Acceleration
08:01am, Thursday, 25'th Apr 2024
Invest in companies such as Zymeworks (ZYME), Evolus (EOLS) and Bilibili (BILI) for superb earnings acceleration.
